Despite a challenging consumer environment, the CEO remains confident due to the strength of the private brands market. However, the company's shares fell 6.36% in premarket trading post-earnings report.
TreeHouse Foods' steady decrease in revenue and share price over the past five years warns potential investors about possible future underperformance. Contrarian investors, however, might see a turnaround opportunity.
The company's CEO expressed optimism about capitalizing on the increasing consumer shift to private brands and believes actions taken to strengthen their portfolio and enhance capabilities, along with reinvestment opportunities, will ensure long-term value creation for shareholders.
The acquisition is expected to deepen TreeHouse Foods' position in the pickle category and facilitate expansion into Canada, potentially positioning the company for continued success.
Gainers: •$根科船务贸易(GNK.US)$+4.7% (positive Barrons article) •$NextDecade(NEXT.US)$+4.7% (files for 4618226 share common stock offering by selling shareholder) •$COMPASS Pathways(CMPS.US)$+4.7% (COMPASS Pathways presents largest ever study of psilocybin therapy at American Psychiatric Association annual meeting) •$Canoo(GOEV.US)$+3.5% (files for 48043111 share common stock offering by selling shareholder) •$American Axle & Mfg(AXL.US)$+3.7% (pr...
Upgrades •$CubeSmart(CUBE.US)$: Raymond James Upgrades to Strong Buy from Outperform - PT $52 (from $60) •$DTE能源(DTE.US)$: Credit Suisse Upgrades to Outperform from Neutral - PT $140 (from $142) •$爱迪生联合电气(ED.US)$: Guggenheim Upgrades to Neutral from Sell - PT $94 (from $80) •$摩托罗拉解决方案(MSI.US)$: Morgan Stanley Upgrades to Overweight from Equalweight - PT $240 •$墨西哥中北部机场(OMAB.US)$: Morgan Stanley Upgrades to...
13
1
14
举报
RDK79 :
Only noted more downgraded than upgrades, lot of analysts late to the party. And a bunch of new ‘initiated’ by mostly unknown folks, but also a few surprised weren’t previously covered, like DIS.
树屋食品股票讨论区
专栏Industries with opportunities for third-quarter financial reports!
$标普500指数(.SPX.US)$$纳斯达克100指数主连(2406)(NQmain.US)$$沃尔玛(WMT.US)$$星巴克(SBUX.US)$$亚马逊(AMZN.US)$$好市多(COST.US)$$礼来(LLY.US)$$麦当劳(MCD.US)$$树屋食品(THS.US)$$达登饭店(DRI.US)$$车美仕(KMX.US)$$温蒂汉堡(WEN.US)$
TOP WATCH 7/3 ⚡️⚡️
$Apyx Medical(APYX.US)$$盈喜集团(ATXG.US)$$Axsome Therapeutics(AXSM.US)$$BioXcel Therapeutics(BTAI.US)$$Baudax Bio(BXRX.US)$$CymaBay Therapeutics(CBAY.US)$$CorMedix(CRMD.US)$$万豪酒店(MAR.US)$$维视图像(MVIS.US)$$Renalytix(RNLX.US)$$道富银行(STT.US)$$树屋食品(THS.US)$$Targa Resources(TRGP.US)$$VBI Vaccines(VBIV.US)$$芬塔公司(VTR.US)$
专栏Today's pre-market stock movers: PLTR, BBBY, BNTX, GOLD and more
In reaction to earnings/guidance:
• $Karuna Therapeutics(KRTX.US)$ +42.6% (also reports topline results from its Phase3 EMERGENT-2 trial evaluating the efficacy, safety, and tolerability of its lead investigational therapy, KarXT), $monday.com(MNDY.US)$ +15.1%,$W&T海底钻探(WTI.US)$ +6.7%,$HF Sinclair(DINO.US)$ +5.3%,$Viatris(VTRS.US)$ +4.3%,$Kosmos Energy(KOS.US)$ + 3.2%,$Holly Energy(HEP.US)$ +3.2%,$巴里克黄金(GOLD.US)$ +2.9%,...
专栏Today's pre-market stock movers: BNTX, JPM, RIVN, HPQ and more
• $根科船务贸易(GNK.US)$ +4.7% (positive Barrons article)
• $NextDecade(NEXT.US)$ +4.7% (files for 4618226 share common stock offering by selling shareholder)
• $COMPASS Pathways(CMPS.US)$ +4.7% (COMPASS Pathways presents largest ever study of psilocybin therapy at American Psychiatric Association annual meeting)
• $Canoo(GOEV.US)$ +3.5% (files for 48043111 share common stock offering by selling shareholder)
• $American Axle & Mfg(AXL.US)$ +3.7% (pr...
专栏Top upgrades and downgrades on 5/23
• $CubeSmart(CUBE.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $52 (from $60)
• $DTE能源(DTE.US)$ : Credit Suisse Upgrades to Outperform from Neutral - PT $140 (from $142)
• $爱迪生联合电气(ED.US)$ : Guggenheim Upgrades to Neutral from Sell - PT $94 (from $80)
• $摩托罗拉解决方案(MSI.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $240
• $墨西哥中北部机场(OMAB.US)$ : Morgan Stanley Upgrades to...
shorts the only thing working for me today
暂无评论